A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
For over-the-counter ibuprofen, you should not take more than 1,200 milligrams per day. Consistently exceeding this amount ...
The new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
President Donald Trump's steep tariffs on Canada, Mexico and China could worsen existing drug shortages in the U.S. and ...
Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...
Nitrous oxide is widely available as long as everyone pretends it’s being used for whipped cream. An industry has arisen to ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...